0001470831-25-000383.txt : 20251205 0001470831-25-000383.hdr.sgml : 20251205 20251205111541 ACCESSION NUMBER: 0001470831-25-000383 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251205 DATE AS OF CHANGE: 20251205 EFFECTIVENESS DATE: 20251205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aminex Therapeutics, Inc. CENTRAL INDEX KEY: 0001613386 ORGANIZATION NAME: EIN: 263969765 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565891 FILM NUMBER: 251551776 BUSINESS ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 BUSINESS PHONE: 425-286-4222 MAIL ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 D 1 primary_doc.xml X0708 D LIVE 0001613386 Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 425-286-4222 WASHINGTON None None Corporation true David Meeks c/o Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 Director Mark Burns c/o Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 Executive Officer Director Don Dyer c/o Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 Director Jeffrey Miller c/o Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 Director Deyaa Adib c/o Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 Director James Skaggs c/o Aminex Therapeutics, Inc. 6830 NE Bothell Way Ste C139 Kenmore WA WASHINGTON 98028 Director Biotechnology Decline to Disclose 06b false 2022-10-25 true true false 0 30000030 15084670 14915360 false 162 0 0 0 false Aminex Therapeutics, Inc. /s/ David Meek David Meek Executive Chairman 2025-12-04